BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

641 related articles for article (PubMed ID: 34493762)

  • 21. Different selection dynamics of S and RdRp between SARS-CoV-2 genomes with and without the dominant mutations.
    Koçhan N; Eskier D; Suner A; Karakülah G; Oktay Y
    Infect Genet Evol; 2021 Jul; 91():104796. PubMed ID: 33667722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SARS-CoV-2 introduction and lineage dynamics across three epidemic peaks in Southern Brazil: massive spread of P.1.
    Varela APM; Prichula J; Mayer FQ; Salvato RS; Sant'Anna FH; Gregianini TS; Martins LG; Seixas A; Veiga ABGD
    Infect Genet Evol; 2021 Dec; 96():105144. PubMed ID: 34798321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploring the Interaction between E484K and N501Y Substitutions of SARS-CoV-2 in Shaping the Transmission Advantage of COVID-19 in Brazil: A Modeling Study.
    Zhao S; Ran J; Han L
    Am J Trop Med Hyg; 2021 Sep; 105(5):1247-1254. PubMed ID: 34583340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. No evidence for increased transmissibility from recurrent mutations in SARS-CoV-2.
    van Dorp L; Richard D; Tan CCS; Shaw LP; Acman M; Balloux F
    Nat Commun; 2020 Nov; 11(1):5986. PubMed ID: 33239633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamics of severe acute respiratory syndrome coronavirus 2 genome variants in the feces during convalescence.
    Xu Y; Kang L; Shen Z; Li X; Wu W; Ma W; Fang C; Yang F; Jiang X; Gong S; Zhang L; Li M
    J Genet Genomics; 2020 Oct; 47(10):610-617. PubMed ID: 33388272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Global and local mutations in Bangladeshi SARS-CoV-2 genomes.
    Hasan MM; Das R; Rasheduzzaman M; Hussain MH; Muzahid NH; Salauddin A; Rumi MH; Mahbubur Rashid SM; Siddiki AZ; Mannan A
    Virus Res; 2021 May; 297():198390. PubMed ID: 33737154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The temporal association of introducing and lifting non-pharmaceutical interventions with the time-varying reproduction number (R) of SARS-CoV-2: a modelling study across 131 countries.
    Li Y; Campbell H; Kulkarni D; Harpur A; Nundy M; Wang X; Nair H;
    Lancet Infect Dis; 2021 Feb; 21(2):193-202. PubMed ID: 33729915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evolution of SARS-CoV-2 Envelope, Membrane, Nucleocapsid, and Spike Structural Proteins from the Beginning of the Pandemic to September 2020: A Global and Regional Approach by Epidemiological Week.
    Troyano-Hernáez P; Reinosa R; Holguín Á
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33557213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estimation and worldwide monitoring of the effective reproductive number of SARS-CoV-2.
    Huisman JS; Scire J; Angst DC; Li J; Neher RA; Maathuis MH; Bonhoeffer S; Stadler T
    Elife; 2022 Aug; 11():. PubMed ID: 35938911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation on the use of Nanopore sequencing for direct characterization of coronaviruses from respiratory specimens, and a study on emerging missense mutations in partial RdRP gene of SARS-CoV-2.
    Chan WS; Au CH; Lam HY; Wang CLN; Ho DN; Lam YM; Chu DKW; Poon LLM; Chan TL; Zee JS; Ma ESK; Tang BSF
    Virol J; 2020 Nov; 17(1):183. PubMed ID: 33225958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SARS-CoV-2 spike evolutionary behaviors; simulation of N501Y mutation outcomes in terms of immunogenicity and structural characteristic.
    Rostami N; Choupani E; Hernandez Y; Arab SS; Jazayeri SM; Gomari MM
    J Cell Biochem; 2022 Feb; 123(2):417-430. PubMed ID: 34783057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The emergence and ongoing convergent evolution of the SARS-CoV-2 N501Y lineages.
    Martin DP; Weaver S; Tegally H; San JE; Shank SD; Wilkinson E; Lucaci AG; Giandhari J; Naidoo S; Pillay Y; Singh L; Lessells RJ; ; ; Gupta RK; Wertheim JO; Nekturenko A; Murrell B; Harkins GW; Lemey P; MacLean OA; Robertson DL; de Oliveira T; Kosakovsky Pond SL
    Cell; 2021 Sep; 184(20):5189-5200.e7. PubMed ID: 34537136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The unique features of SARS-CoV-2 transmission: Comparison with SARS-CoV, MERS-CoV and 2009 H1N1 pandemic influenza virus.
    Wu Z; Harrich D; Li Z; Hu D; Li D
    Rev Med Virol; 2021 Mar; 31(2):e2171. PubMed ID: 33350025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Prevalence of Protein S Variant in Patients Diagnosed with COVID-19.
    Bayirli-Turan D; Usanmaz M; Gorgun S; Yolcu E; Sahin C; Bilenoglu O; Isbilen M; Yildiz E
    Clin Lab; 2022 Oct; 68(10):. PubMed ID: 36250839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An Evolutionary Portrait of the Progenitor SARS-CoV-2 and Its Dominant Offshoots in COVID-19 Pandemic.
    Kumar S; Tao Q; Weaver S; Sanderford M; Caraballo-Ortiz MA; Sharma S; Pond SLK; Miura S
    Mol Biol Evol; 2021 Jul; 38(8):3046-3059. PubMed ID: 33942847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The extent of molecular variation in novel SARS-CoV-2 after the six-month global spread.
    Bui NN; Lin YT; Huang SH; Lin CW
    Infect Genet Evol; 2021 Jul; 91():104800. PubMed ID: 33677109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early trends for SARS-CoV-2 infection in central and north Texas and impact on other circulating respiratory viruses.
    Mutnal MB; Arroliga AC; Walker K; Mohammad A; Brigmon MM; Beaver RM; Midturi JK; Rao A
    J Med Virol; 2020 Oct; 92(10):2130-2138. PubMed ID: 32410236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The evolution of SARS-CoV-2 and the COVID-19 pandemic.
    Si Y; Wu W; Xue X; Sun X; Qin Y; Li Y; Qiu C; Li Y; Zhuo Z; Mi Y; Zheng P
    PeerJ; 2023; 11():e15990. PubMed ID: 37701824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sequencing Using a Two-Step Strategy Reveals High Genetic Diversity in the S Gene of SARS-CoV-2 after a High-Transmission Period in Tunis, Tunisia.
    Fares W; Ghedira K; Gdoura M; Chouikha A; Haddad-Boubaker S; Khedhiri M; Ayouni K; Lamari A; Touzi H; Hammemi W; Medeb Z; Sadraoui A; Hogga N; Ben Alaya N; Triki H
    Microbiol Spectr; 2021 Dec; 9(3):e0063921. PubMed ID: 34756072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.